AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

VNF 37.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Beekay Pharmaceuticals

Salt Composition

Venlafaxine (37.5mg)

Overview VNF 37.5mg Tablet

Axonil 37.5mg tablets are indicated for managing depressive and anxiety disorders. This medication modifies brain chemistry, alleviating anxiety symptoms like agitation, unease, poor concentration, tiredness, perspiration, tachycardia, and intrusive thoughts. Axonil 37.5mg should be administered with food, consistently at the same time daily for optimal blood levels. Missed doses should be taken immediately upon recollection; avoid skipping doses and complete the prescribed course, even with symptom improvement. Abrupt cessation is contraindicated due to potential symptom exacerbation. Common adverse effects include nausea, vomiting, sleep disturbances, reduced appetite, heightened anxiety, constipation, hyperhidrosis, and sexual dysfunction. Dizziness and somnolence may occur; avoid operating machinery or engaging in activities demanding alertness until the medication's effects are known. These side effects are generally transient and self-limiting. Consult your physician if side effects persist or are troublesome. Prior to commencing Axonil 37.5mg, disclose any renal, cardiac, hepatic impairment, or history of seizures. Report any unusual mood or behavioral changes, worsening depression, or suicidal ideation to your doctor immediately.

Uses of VNF 37.5mg Tablet

Mood and anxiety disorders

Major Benefits of VNF 37.5mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The VNF 37.5mg Tablet should be administered with a meal.

Common Side effects of VNF 37.5mg Tablet:

  • Nausea
  • Vomiting
  • Dizziness
  • Insomnia (difficulty in sleeping)
  • Decreased appetite
  • Anxiety
  • Constipation
  • Increased sweating
  • Sexual dysfunction

How to use VNF 37.5mg Tablet:

Your physician will determine the correct dosage and treatment length for this medication. Ingest the 37.5mg VNF tablet whole with food; do not crush, chew, or break it.

How VNF 37.5mg Tablet works:

VNF 37.5mg tablets elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking VNF 37.5mg tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using VNF 37.5mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against these risks before prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of VNF 37.5mg tablets while breastfeeding is likely inadvisable. Preliminary research indicates potential transfer of the medication into breast milk, posing a possible risk to the infant. Close observation of newborns for drowsiness and satisfactory weight increase is recommended.

DrivingDrivingUNSAFE

Taking a 37.5mg VNF tablet may induce adverse reactions that impair driving. These reactions can include dizziness, confusion, and visual disturbances like blurred vision, all potentially affecting driving ability.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using VNF 37.5mg tablets. A modified dosage of VNF 37.5mg tablets may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using VNF 37.5mg tablets; dosage modification may be necessary. Physician consultation is recommended.

What if you forget to take VNF 37.5mg Tablet :

Should you forget a VNF 37.5mg Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About VNF 37.5mg Tablet

LabelValue
Type of Compound Phenyl methyl ether
Potential for Dependence None.
Type of Medication Nervous system medication.
Mechanism of Action Drugs that inhibit the reuptake of serotonin and norepinephrine.

FAQs on VNF 37.5mg Tablet

Indeed, the 37.5mg VNF Tablet may induce drowsiness. Prior to commencing treatment with 37.5mg VNF Tablets, disclose any concurrent use of sleep-promoting medications to your physician.
Indeed. VNF 37.5mg tablets are classified as a psychotropic medication. Psychotropic medications are defined as any substance impacting mental processes, mood, and conduct.
VNF 37.5mg tablets are not classified as narcotics. Narcotics are characterized by their sedative effects and are typically derived from opium, such as heroin and morphine.
These are identical medications. VNF 37.5mg tablets, in both ER and XR formulations, are extended-release versions delivering the drug gradually for consistent therapeutic levels. Extended-release tablets reduce the required dosing frequency.
Mirtazapine and VNF 37.5mg tablets should not be used together. Concurrent use poses a significant risk of serotonin syndrome, a potentially fatal condition. Symptoms may include restlessness, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, fever, and unconsciousness.
Concomitant use of citalopram and VNF 37.5mg tablets elevates serotonin levels, posing a risk of serotonin syndrome. This potentially fatal condition may manifest as restlessness, perceptual distortions, nausea, emesis, diarrhea, rapid heart rate, fluctuating blood pressure, fever, and unconsciousness. An alternative medication is recommended.
VNF 37.5mg Tablet is actively removed from the brain by P-glycoprotein. However, research indicates that this medication and its byproduct can suppress P-glycoprotein activity.
The liver processes VNF 37.5mg tablets, which are then absorbed into the body via the intestines.
Depresion medication VNF 37.5mg tablets are indicated for generalized depressive disorder. Physician consultation is required prior to use.
Treatment with VNF 37.5mg tablets may cause persistently elevated blood pressure in certain individuals. Regular blood pressure checks are advised for patients using VNF 37.5mg tablets. A lower dosage or treatment cessation may be necessary for these patients.
Indeed, VNF 37.5mg tablets can induce constipation in certain individuals. A high-fiber diet and increased water intake are recommended. Laxatives may also be beneficial. Your physician can advise on preventative measures and management strategies. Seek medical attention if the constipation persists or worsens.
Indeed, some individuals taking VNF 37.5mg tablets experience weight reduction. Clinical trials indicated that weight loss correlated with the dosage of VNF 37.5mg tablets administered over a period of weeks. Seek medical advice should this side effect be concerning.
VNF 37.5mg Tablets are not considered habit-forming.
Capsules may be substituted with tablets only with a physician's guidance. Self-initiated changes are inadvisable, as varying drug formulations impact medication release, potentially resulting in ineffective treatment, adverse reactions, or treatment failure.
Concurrent use of gabapentin and VNF 37.5mg tablets is permissible, but only under strict medical supervision. Combined administration may heighten drowsiness, lethargy, and impair concentration. Proceed with caution.
Desvenlafaxine, the active component of VNF 37.5mg Tablet, is the medication in its pharmacologically active state.
The 37.5mg VNF tablet lacks regulatory approval for fibromyalgia treatment. Preliminary research suggests potential efficacy in managing fibromyalgia, but further investigation is needed. Physician consultation is mandatory prior to VNF 37.5mg tablet use.
The medication VNF 37.5mg Tablet lacks formal approval for nerve pain, yet studies suggest its effectiveness in managing this condition. Consequently, it's presently employed for nerve pain in an unapproved capacity.
VNF 37.5mg tablets affect neurotransmitter and brain chemical levels, resulting in reduced appetite. This appetite suppression is directly related to the dosage.
Should you experience reduced libido or erectile dysfunction, consult your physician to explore alternative treatment options. Do not discontinue VNF 37.5mg Tablet independently; this may worsen side effects.
VNF 37.5mg Tablet
27
MRP 33
18% off